Heron Therapeutics
HRTX
#8261
Rank
S$0.31 B
Marketcap
S$1.70
Share price
0.00%
Change (1 day)
-27.70%
Change (1 year)

Heron Therapeutics (HRTX) - Net assets

Net assets on the balance sheet as of September 2025 : S$19.28 Million

According to Heron Therapeutics's latest financial reports the company has S$19.28 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Heron Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-S$45.75 Million1.94%
2023-12-31$-S$44.87 Million-346.6%
2022-12-31$S$18.19 M-82.65%
2021-12-31$S$0.10 B-66.48%
2020-12-31$S$0.31 B-42.53%
2019-12-31$S$0.54 B7.66%
2018-12-31$S$0.50 B188.32%
2017-12-31$S$0.17 B-670.27%
2016-12-31$-S$30.76 Million-118.41%
2015-12-31$S$0.16 B100.5%
2014-12-31$S$83.32 M-4.61%
2013-12-31$S$87.35 M37.85%
2012-12-31$S$63.36 M210.63%
2011-12-31$S$20.39 M1103.4%
2010-12-31$S$1.69 M-82.23%
2009-12-31$S$9.54 M-12.19%
2008-12-31$S$10.86 M-74.38%
2007-12-31$S$42.41 M129.37%
2006-12-31$S$18.49 M79.04%
2005-12-31$S$10.32 M-55.27%
2004-12-31$S$23.09 M20.67%
2003-12-31$S$19.13 M-28.66%
2002-12-31$S$26.82 M-24.42%
2001-12-31$S$35.48 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Alkermes
ALKS
S$2.24 B 11,545.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
S$0.94 B 4,785.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$0.11 B 471.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.23 B 6,283.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
S$0.14 B 647.79%๐Ÿ‡บ๐Ÿ‡ธ USA